Visalytics
Visalytics
dismissed EB-2 (NIW)

Senior Manager IT Operations Management

Pharmaceutical Company · 2024-10-21

Decision Date
2024-10-21
This case is from a USCIS Administrative Appeals Office (AAO) appeal decision. Appeal cases represent a subset of petitions and may not reflect typical outcomes.

Proposed Endeavor

The Beneficiary proposes to streamline and ensure the quality of pharmaceutical research, development, and regulatory approval processes through the development, enhancement, and maintenance of cloud, DevOps, and database systems. This involves enhancing clinical data management systems to automate drug development, protect sensitive patient data, and integrate cloud and AI automation technologies to optimize the process.

Framework Evaluation

0 of 3 criteria met
1 The proposed endeavor has both substantial merit and national importance Not Met

The AAO found that while the Director determined the proposed endeavor had substantial merit, the Petitioner did not establish its national importance, as it failed to show broader impact beyond the company, significant U.S. job creation, or substantial positive economic effects.

Why This Petition Was Denied

The appeal was dismissed because the Petitioner failed to demonstrate the national importance of the proposed endeavor under the first Dhanasar prong. USCIS found insufficient evidence that the Beneficiary's work would have a broader impact beyond the Petitioner's company, create significant U.S. jobs, or have substantial positive economic effects. The importance of the field itself was not considered sufficient to establish national importance for the specific endeavor.

Evidence

Evidence Types
Peer Reviewed Publications
Conference Presentations
Patents

Similar Cases

Others

Pharmaceuticals · India

USCIS EB-2 (NIW) dismissed
2024-11-18
The Beneficiary proposes to continue working as an Associate Director, Master Data Management (MDM) Implementation Lead for a pharmaceutical company. His endeavor involves developing, implementing, and managing digital platforms using AI and machine learning to optimize laboratory workflows, integrate clinical trial data, ensure data security, improve access to high-quality information, and accelerate drug research, development, and regulatory approval processes.

Chief Executive Officer (CEO)

Pharmaceuticals

USCIS EB-2 (NIW) rfe dismissed
Florida 2024-04-19
The petitioner proposes to launch and develop a Florida-based company focused on a digital learning and instruction platform for pharmaceutical sales professionals. The endeavor involves coaching sales teams and developing commercial chains for American products, specifically in ophthalmology-related pharmaceuticals, to help U.S. companies reach international markets.

Pharmacist

Pharmaceuticals

USCIS EB-2 (NIW) rfe dismissed
Florida 2025-03-31
The petitioner proposes to operate a comprehensive pharmaceutical service providing online health services and pharmaceuticals to patients across the country. The endeavor focuses on healthcare outcomes for vulnerable populations, such as the elderly and those with chronic conditions, through medication dispensing and patient education.

General Manager

Pharmaceuticals

USCIS EB-2 (NIW) rfe dismissed
Virginia 2025-04-07
The petitioner proposes to operate a chain of pharmacies providing low and average cost prescription medicines to elderly and economically disadvantaged communities. The plan involves establishing a headquarters in Virginia and expanding to Maryland, focusing on affordable quality medicine.

Frequently Asked Questions

A dismissed EB-2 NIW petition means USCIS found the evidence insufficient to meet the eligibility criteria. Common reasons include weak documentation, failure to meet the required number of criteria, or insufficient evidence of the claimed qualifications. Petitioners can refile with stronger evidence or explore alternative visa categories.

Browse More Cases

More dismissed cases More Pharmaceuticals cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-10-21.

Browse all cases

At a Glance

Outcome dismissed
Criteria Met 0 / 3
Evidence Types 3

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist